Go Pro

Amdocs (DOX) Competitors

Amdocs logo
$62.91 +0.21 (+0.33%)
As of 08/28/2026 04:00 PM Eastern

DOX vs. CTSH, SSNC, ACN, GIB, and WIT

Should you buy Amdocs stock or one of its competitors? Amdocs's main competitors and comparable companies include Cognizant Technology Solutions (CTSH), SS&C Technologies (SSNC), Accenture (ACN), CGI Group (GIB), and Wipro (WIT). Companies are selected based on similarities in market, industry, and size.

How does Amdocs compare to Cognizant Technology Solutions?

Cognizant Technology Solutions (NASDAQ:CTSH) and Amdocs (NASDAQ:DOX) are both technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Cognizant Technology Solutions has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

92.4% of Cognizant Technology Solutions shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 0.4% of Cognizant Technology Solutions shares are held by company insiders. Comparatively, 15.4% of Amdocs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cognizant Technology Solutions presently has a consensus price target of $63.00, indicating a potential downside of 1.62%. Amdocs has a consensus price target of $86.67, indicating a potential upside of 37.76%. Given Amdocs' higher probable upside, analysts clearly believe Amdocs is more favorable than Cognizant Technology Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cognizant Technology Solutions
1 Sell rating(s)
13 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.38
Amdocs
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.1%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.6%. Cognizant Technology Solutions pays out 28.4% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognizant Technology Solutions has increased its dividend for 6 consecutive years and Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Amdocs had 11 more articles in the media than Cognizant Technology Solutions. MarketBeat recorded 18 mentions for Amdocs and 7 mentions for Cognizant Technology Solutions. Cognizant Technology Solutions' average media sentiment score of 0.85 beat Amdocs' score of 0.63 indicating that Cognizant Technology Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cognizant Technology Solutions
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Amdocs
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cognizant Technology Solutions has a net margin of 10.26% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Cognizant Technology Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Cognizant Technology Solutions10.26% 17.70% 12.81%
Amdocs 9.75%20.28%10.94%

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cognizant Technology Solutions$21.11B1.37$2.23B$4.6513.77
Amdocs$4.53B1.50$564.70M$4.2014.98

Summary

Cognizant Technology Solutions beats Amdocs on 11 of the 19 factors compared between the two stocks.

How does Amdocs compare to SS&C Technologies?

Amdocs (NASDAQ:DOX) and SS&C Technologies (NASDAQ:SSNC) are related companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

SS&C Technologies has a net margin of 13.16% compared to Amdocs' net margin of 9.75%. SS&C Technologies' return on equity of 21.20% beat Amdocs' return on equity.

Company Net Margins Return on Equity Return on Assets
Amdocs9.75% 20.28% 10.94%
SS&C Technologies 13.16%21.20%7.19%

92.0% of Amdocs shares are held by institutional investors. Comparatively, 96.9% of SS&C Technologies shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 16.0% of SS&C Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.6%. SS&C Technologies pays an annual dividend of $1.20 per share and has a dividend yield of 1.4%. Amdocs pays out 54.3% of its earnings in the form of a dividend. SS&C Technologies pays out 34.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has raised its dividend for 14 consecutive years and SS&C Technologies has raised its dividend for 9 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Amdocs has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, SS&C Technologies has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

In the previous week, SS&C Technologies had 12 more articles in the media than Amdocs. MarketBeat recorded 30 mentions for SS&C Technologies and 18 mentions for Amdocs. SS&C Technologies' average media sentiment score of 1.66 beat Amdocs' score of 0.63 indicating that SS&C Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amdocs
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
SS&C Technologies
29 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.53B1.50$564.70M$4.2014.98
SS&C Technologies$6.56B2.98$796.90M$3.4823.97

Amdocs presently has a consensus price target of $86.67, suggesting a potential upside of 37.76%. SS&C Technologies has a consensus price target of $91.25, suggesting a potential upside of 9.39%. Given Amdocs' higher possible upside, analysts plainly believe Amdocs is more favorable than SS&C Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amdocs
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
SS&C Technologies
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.78

Summary

SS&C Technologies beats Amdocs on 15 of the 20 factors compared between the two stocks.

How does Amdocs compare to Accenture?

Amdocs (NASDAQ:DOX) and Accenture (NYSE:ACN) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Amdocs presently has a consensus price target of $86.67, indicating a potential upside of 37.76%. Accenture has a consensus price target of $194.19, indicating a potential upside of 2.43%. Given Amdocs' higher probable upside, equities research analysts clearly believe Amdocs is more favorable than Accenture.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amdocs
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
Accenture
1 Sell rating(s)
14 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.41

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.53B1.50$564.70M$4.2014.98
Accenture$69.67B1.82$7.68B$12.5215.14

92.0% of Amdocs shares are held by institutional investors. Comparatively, 75.1% of Accenture shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 0.0% of Accenture shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.6%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.4%. Amdocs pays out 54.3% of its earnings in the form of a dividend. Accenture pays out 52.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and Accenture has increased its dividend for 20 consecutive years.

Accenture has a net margin of 10.66% compared to Amdocs' net margin of 9.75%. Accenture's return on equity of 26.47% beat Amdocs' return on equity.

Company Net Margins Return on Equity Return on Assets
Amdocs9.75% 20.28% 10.94%
Accenture 10.66%26.47%12.89%

In the previous week, Accenture had 3 more articles in the media than Amdocs. MarketBeat recorded 21 mentions for Accenture and 18 mentions for Amdocs. Accenture's average media sentiment score of 0.86 beat Amdocs' score of 0.63 indicating that Accenture is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amdocs
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Accenture
11 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Amdocs has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Accenture has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

Summary

Accenture beats Amdocs on 15 of the 19 factors compared between the two stocks.

How does Amdocs compare to CGI Group?

CGI Group (NYSE:GIB) and Amdocs (NASDAQ:DOX) are both technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

CGI Group has higher revenue and earnings than Amdocs. CGI Group is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CGI Group$11.38B1.39$1.19B$5.8312.81
Amdocs$4.53B1.50$564.70M$4.2014.98

In the previous week, Amdocs had 15 more articles in the media than CGI Group. MarketBeat recorded 18 mentions for Amdocs and 3 mentions for CGI Group. Amdocs' average media sentiment score of 0.63 beat CGI Group's score of 0.32 indicating that Amdocs is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CGI Group
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Amdocs
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

CGI Group pays an annual dividend of $0.48 per share and has a dividend yield of 0.6%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.6%. CGI Group pays out 8.2% of its earnings in the form of a dividend. Amdocs pays out 54.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CGI Group has a net margin of 10.54% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat CGI Group's return on equity.

Company Net Margins Return on Equity Return on Assets
CGI Group10.54% 18.83% 9.83%
Amdocs 9.75%20.28%10.94%

CGI Group presently has a consensus target price of $83.67, suggesting a potential upside of 12.05%. Amdocs has a consensus target price of $86.67, suggesting a potential upside of 37.76%. Given Amdocs' stronger consensus rating and higher probable upside, analysts clearly believe Amdocs is more favorable than CGI Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CGI Group
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Amdocs
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

66.7% of CGI Group shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 9.9% of CGI Group shares are held by insiders. Comparatively, 15.4% of Amdocs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CGI Group has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Summary

Amdocs beats CGI Group on 13 of the 19 factors compared between the two stocks.

How does Amdocs compare to Wipro?

Amdocs (NASDAQ:DOX) and Wipro (NYSE:WIT) are both technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.6%. Wipro pays an annual dividend of $0.04 per share and has a dividend yield of 2.2%. Amdocs pays out 54.3% of its earnings in the form of a dividend. Wipro pays out 30.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Amdocs had 16 more articles in the media than Wipro. MarketBeat recorded 18 mentions for Amdocs and 2 mentions for Wipro. Amdocs' average media sentiment score of 0.63 beat Wipro's score of 0.10 indicating that Amdocs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amdocs
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Wipro
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

92.0% of Amdocs shares are held by institutional investors. Comparatively, 2.4% of Wipro shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 1.0% of Wipro shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Amdocs presently has a consensus price target of $86.67, indicating a potential upside of 37.76%. Wipro has a consensus price target of $1.70, indicating a potential downside of 6.08%. Given Amdocs' stronger consensus rating and higher probable upside, equities analysts plainly believe Amdocs is more favorable than Wipro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amdocs
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
Wipro
3 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.25

Wipro has a net margin of 13.93% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Wipro's return on equity.

Company Net Margins Return on Equity Return on Assets
Amdocs9.75% 20.28% 10.94%
Wipro 13.93%15.40%9.67%

Amdocs has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Wipro has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

Wipro has higher revenue and earnings than Amdocs. Wipro is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amdocs$4.53B1.50$564.70M$4.2014.98
Wipro$9.87B1.81$1.41B$0.1313.92

Summary

Amdocs beats Wipro on 13 of the 19 factors compared between the two stocks.

Get Amdocs News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOX vs. The Competition

MetricAmdocsIT Services IndustryTechnology SectorNASDAQ Exchange
Market Cap$6.77B$11.14B$30.15B$12.93B
Dividend Yield3.63%2.77%2.74%11.02%
P/E Ratio14.9814.3276.1025.41
Price / Sales1.5061.23594.8796.93
Price / Cash8.0043.2050.2654.21
Price / Book2.0425.159.356.14
Net Income$564.70M$268.46M$677.60M$347.93M
7 Day Performance2.46%-0.53%-0.10%-0.78%
1 Month Performance10.72%6.13%6.25%5.60%
1 Year Performance-26.48%29.64%187.14%15.64%

Amdocs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOX
Amdocs
4.7325 of 5 stars
$62.91
+0.3%
$86.67
+37.8%
-25.6%$6.77B$4.53B14.9826,969
CTSH
Cognizant Technology Solutions
3.7189 of 5 stars
$60.92
0.0%
$63.00
+3.4%
-10.7%$27.44B$21.11B13.10351,600
SSNC
SS&C Technologies
4.8314 of 5 stars
$82.12
-0.2%
$91.25
+11.1%
-5.6%$19.27B$6.56B23.6028,800
ACN
Accenture
4.0618 of 5 stars
$181.58
-0.9%
$192.96
+6.3%
-26.0%$121.26B$69.67B14.50779,000
GIB
CGI Group
2.4212 of 5 stars
$74.16
-1.0%
$83.67
+12.8%
-22.6%$15.68B$11.38B12.7294,000

Related Companies and Tools


This page (NASDAQ:DOX) was last updated on 8/29/2026 by MarketBeat.com Staff.
From Our Partners